NCT01714739 · Interventional trial
A Study of an Anti-KIR Antibody Lirilumab in Combination With an Anti-PD1 Antibody Nivolumab and Nivolumab Plus an Anti-CTLA-4 Ipilimumab Antibody in Patients With Advanced Solid Tumors
Overall registry status Completed
Phase 1 · Phase 2
Conditions CANCER,NOS
Delaware Valley sites
- Thomas Jefferson University Hospital · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory